The  Nobel Prize in Physiology or Medicine for 2006 is awarded to Andrew 
  Fire, PhD, of Stanford University School of Medicine, and Craig C. Mello, PhD, 
  of the University of Massachusetts Medical School, for their discoveries 
  related to RNA interference.
  
Fire, Mello and colleagues discovered that certain RNA molecules could be 
  used to turn off specific genes in animal cells. The silencing process—called 
  RNA interference, or RNAi — has become a widespread research tool. Their 
  findings were published  in Nature in 1998. In their experiments, the 
  scientists silenced silence an individual gene in 
  Caenorhabditis elegans 
  by injecting a double-stranded version of its messenger RNA. This “RNA 
  silencing” has since been shown to work in nearly every animal cell.
  Here is the abstract of their 1998 paper:
  
    Fire A, Xu SQ,
    Montgomery MK, Kostas SA,
    Driver SE, Mello CC. 1998
    Potent and specific genetic interference by double-stranded RNA in 
    Caenorhabditis elegans. Nature 391: 806-811. 
  
  
    Abstract: Experimental introduction of RNA 
    into cells can be used in certain biological systems to interfere with 
    function of an endogenous gene. Such effects have been proposed io result 
    from a simple antisense mechanism that depends on hybridization between the 
    injected RNA and endogenous messenger RNA transcripts, RNA interference has 
    been used in the nematode Caenorhabditis elegans to manipulate gene 
    expression. Here we investigate the requirements for structure and delivery 
    of the interfering RNA. To our surprise, we found that double-stranded RNA 
    was substantially more effective at producing interference than was either 
    strand individually. After injection into adult animals, purified single 
    strands had at most a modest effect, whereas double-stranded mixtures caused 
    potent and specific interference. The effects of this interference were 
    evident in bath the injected animals and their progeny. Only a few molecules 
    of injected double-stranded RNA were required per affected cell, arguing 
    against stochiometric interference with endogenous mRNA and suggesting that 
    there could be a catalytic or amplification component in the interference 
    process.
  
  Return to "In the News - 2006"
  Go to Nemaplex Home Page